Inactive Instrument

XPED Stock Australian S.E.

Advanced Medical Equipment & Technology

End-of-day quote Australian S.E.
- ^AUD	-

02-12	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
22/08/25	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2025	CI

Oakridge International Limited is an Australia-based Internet of things (IoT) and healthcare technology company. The Company is primarily engaged in the business of selling professional healthcare technology equipment and solutions to healthcare facilities. The Companyâ€™s segments include Healthcare technology, Technology development and Geothermal projects. The Technology development segment is focused on the IoT technology. The Healthcare technology segment operates through its wholly owned subsidiary, JCT Healthcare Pty Ltd (JCT), which is a provider of technology solutions for the healthcare sector. JCT develops and distributes its own range of nurse call hardware and software solutions for use across multiple healthcare sectors including hospitals, aged care, disability care and supported independent living. The Geothermal projects segment includes Sokoria Geothermal Project, Ngebel Geothermal Project, Dairi Prima Geothermal Project and Puga Geothermal Project.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	1.94M 1.38M 1.19M 1.12M 1.02M 1.91M 132M 13.1M 5.12M 65.99M 5.17M 5.06M 219M	P/E 2024	-1.65x	P/E 2025	-13.4x
Enterprise Value	1.68M 1.19M 1.03M 965K 877K 1.65M 114M 11.3M 4.42M 56.92M 4.46M 4.37M 189M	EV / Sales 2024	1.07x	EV / Sales 2025	0.6x
Free-Float	22.21%	Yield 2024 *	-	Yield 2025	-

02-12	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
22/08/25	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2025	CI
03/03/25	Oakridge International Limited Announces Board Changes	CI
19/02/25	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2024	CI
29/08/24	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2024	CI
16/04/24	Oakridge International Enters AU$500,000 Shares and Option Subscription Agreement	MT
06/03/24	Oakridge International Gets Nearly AU$180,000 R&D Tax Rebate	MT
28/02/24	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI
21/08/23	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2023	CI
29/03/23	Oakridge International Limited Announces Change of Principal Place of Business	CI
17/02/23	Oakridge International Shrinks Fiscal H1 Loss by 61%	MT
17/02/23	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2022	CI
23/08/22	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2022	CI

21/12/21	Oakridge International : Unmarketable Parcel Sale Facility	PU
02/06/17	XPED Ltd Company Update	AW
02/06/17	XPED Ltd Receives 20 Million Unit Order for iPark	AW
22/05/17	XPED Ltd Complete Jemsoft Acquisition	AW
19/05/17	XPED Ltd Lenze App Delivered	AW

Manager	Title	Age	Since
Con Unerkov CEO	Chief Executive Officer	57	03/02/2021
Julie Edwards SEC	Corporate Secretary	-	-

Director	Title	Age	Since
Con Unerkov CHM	Chairman	57	31/12/2019
Peter Whelan BRD	Director/Board Member	-	29/01/2021
Wally Pastuch BRD	Director/Board Member	-	03/03/2025

XPED Stock Australian S.E.

Stocks

Advanced Medical Equipment & Technology

Valuation: XPED

Latest news : XPED

Press Releases: XPED

Managers and Directors: XPED

Medical Software & Technology Services

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VEEVA SYSTEMS INC.	-3.52%	+5.76%	-13.14%	+27.47%	39.6B
PRO MEDICUS LIMITED	-2.64%	+1.58%	-42.95%	+146.67%	13.25B
SECTRA AB	+1.72%	+5.91%	-18.62%	+77.11%	5.74B
HEARTFLOW, INC.	+35.70%	+46.01%	+35.00%	-	3.66B
GENERATE BIOMEDICINES, INC.	+4.06%	+8.99%	-	-	2.01B
OMNICELL, INC.	-0.90%	+1.33%	+17.70%	-42.33%	1.7B
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	-3.16%	-5.28%	-40.41%	-	967M
ARBUTUS BIOPHARMA CORPORATION	+1.97%	+0.86%	+38.78%	+134.67%	924M
B-SOFT CO.,LTD.	-0.82%	+0.28%	-32.47%	-47.25%	836M
Average	+3.60%	+3.99%	-7.01%	+49.39%	7.63B
Weighted average by Cap.	-0.42%	+5.39%	-16.02%	+56.19%

	2024	2025
Net sales	1.18M 834K 721K 677K 616K 1.16M 79.79M 7.94M 3.1M 39.96M 3.13M 3.06M 133M	2.43M 1.73M 1.49M 1.4M 1.27M 2.39M 165M 16.4M 6.41M 82.6M 6.48M 6.34M 275M
Net income	-761K -540K -466K -438K -398K -749K -51.6M -5.13M -2.01M -25.84M -2.03M -1.98M -85.87M	-129K -91.31K -78.86K -74.1K -67.39K -127K -8.73M -868K -339K -4.37M -343K -335K -14.53M
Net Debt	-661K -468K -404K -380K -346K -650K -44.78M -4.45M -1.74M -22.42M -1.76M -1.72M -74.51M	-267K -189K -163K -154K -140K -263K -18.1M -1.8M -704K -9.06M -711K -695K -30.12M